hydroxyurea has been researched along with Lipodystrophy in 4 studies
Lipodystrophy: A collection of heterogenous conditions resulting from defective LIPID METABOLISM and characterized by ADIPOSE TISSUE atrophy. Often there is redistribution of body fat resulting in peripheral fat wasting and central adiposity. They include generalized, localized, congenital, and acquired lipodystrophy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, J | 1 |
| Hou, D | 1 |
| Annis, J | 1 |
| Sargolzaeiaval, F | 1 |
| Appelbaum, J | 1 |
| Takahashi, E | 1 |
| Martin, GM | 1 |
| Herr, A | 1 |
| Oshima, J | 1 |
| Hanna, L | 1 |
| Carr, A | 1 |
| Hudson, J | 1 |
| Chuah, J | 1 |
| Mallal, S | 1 |
| Law, M | 1 |
| Hoy, J | 1 |
| Doong, N | 1 |
| French, M | 1 |
| Smith, D | 1 |
| Cooper, DA | 1 |
1 trial available for hydroxyurea and Lipodystrophy
| Article | Year |
|---|---|
HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study.
Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Composition; Carnitine; Dideox | 2001 |
3 other studies available for hydroxyurea and Lipodystrophy
| Article | Year |
|---|---|
Inactivating Mutations in Exonuclease and Polymerase Domains in DNA Polymerase Delta Alter Sensitivities to Inhibitors of dNTP Synthesis.
Topics: Base Sequence; Binding Sites; Cell Line; Deafness; Deoxyribonucleotides; DNA Polymerase III; Exonucl | 2020 |
Double protease inhibitor combinations.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; DNA, Viral; Drug Therapy, Combinati | 1998 |
A new approach to initial antiretroviral therapy: protease-sparing combination regimens.
Topics: Alkynes; Anti-HIV Agents; Antineoplastic Agents; Benzoxazines; Clinical Trials as Topic; Cyclopropan | 1998 |